中文

力诺药包 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-25

力诺药包 reported revenue of ¥0.67B for the period ended 2026-06-30, +34.9% year on year. Net income was ¥0.03B, a 4.6% net margin on a 22.7% gross margin. The largest revenue line is 耐热玻璃 at 65% of the total. Free cash flow for the period was ¥-0.17B.

ItemAmountY/Y
Revenue¥0.67B+34.9%
Gross profit¥0.15B
Operating income¥0.04B
Net income¥0.03B-23.9%
Gross margin22.7%Net margin 4.6%
Revenue Q/Q+10.2%

Revenue Segments

SegmentRevenueShare
耐热玻璃¥0.44B64.8%
药用玻璃¥0.23B33.7%
其他(补充)¥0.01B1.5%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.52B77.3%
R&D¥0.02B2.9%
SG&A¥0.08B12.3%
Tax & other¥0.01B1.4%

Balance sheet & cash flow

ItemAmount
Total assets¥2.83B
Total liabilities¥0.88B
Shareholders' equity¥1.95B
Equity / assets69.0%
Operating cash flow¥-0.05B
Capital expenditure¥0.12B
Free cash flow¥-0.17B
Cash conversion (OCF / net income)-219%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

奥尼电子善水科技菲菱科思泰祥股份家联科技北路智控唯科科技工大科雅喜悦智行迈赫股份大族数控诚达药业

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies